SeroVital-hgh
Allegations: Falsely marketing that supplements increase human growth hormone (HGH) levels by 682%, make users look decades younger, and provide various anti-aging benefits
SeroVital-hgh Supplements
December 2023: The lawsuit was transferred from a court in California to a court in Utah. (Case No. 23-cv-889, D. Utah)
May 2022: Plaintiffs filed an amended complaint.
May 2018: A class-action lawsuit was filed against SanMedica International for allegedly falsely advertising the Human Growth Hormone (HGH) supplement SeroVital-hgh. Specifically, plaintiffs claim that SanMedica falsely markets the supplement as able to increase HGH levels by 682% when, according to the complaint, it does increase HGH levels at all. In addition, the complaint alleges that the supplement reduces wrinkles, decreases body fat, increases lean muscle mass, makes stronger bones, improves mood, and heightens sex drive when, according to plaintiffs, the product does not provide any of these benefits. (Pizana et al v. SanMedica International, LLC, Case No. 18-cv-644, E.D. Cal.)
For more of TINA.org’s coverage of SeroVital-hgh, click here.
Class-Action Tracker
The Latest
HydroJug’s Heat-Retention Claims
Can these bottles really keep drinks hot for up to six hours?
With Personalized Pricing, Disclosure Is a Start, But Not a Finish Line
TINA.org and other consumer advocates file comment with FTC.
MLMs Are Consistently Leaving Participants Behind
New book explores why MLMs are often associated with harmful outcomes – and what can be done about it.
Bytech America’s Made in USA Claims
Marketing and reality are not in sync.
CATrends: Chips Made with Avocado Oil
New study opens the floodgates to class-action litigation.